S3844 Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital, profound deafness

Short descriptor: Dna analysis deafness

✓ Active HCPCS Level II 2026
Open S3844 in the app →

Look up S3844 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

S3844 is the HCPCS Level II code for Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital, profound deafness (2026). It belongs to Section S — Temporary National Codes (Non-Medicare). Under Medicare, its coverage status is: Not payable by Medicare. Part B pricing methodology: Not separately priced by Part B.

Classification & CMS Attributes

Medicare Coverage
Not payable by Medicare (code I)
Part B Pricing
Not separately priced by Part B (indicator 00)
Type of Service
Other medical items or services
Effective Date
2003-07-01
2026 Maintenance
No change this year

References

Cite This Page

Reference S3844 with the canonical source and edition:

S3844 — Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital, profound deafness. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/S3844

Canonical URL: https://icd10codingpro.com/hcpcs-codes/S3844

Related Codes in Section S

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial